Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors

The chimeric antibodies anti-CD20 rituximab (Rtx) and anti-TNFα infliximab (Ifx) induce antidrug antibodies (ADAs) in many patients with inflammatory diseases. Because of the key role of CD4 T lymphocytes in the initiation of antibody responses, we localized the CD4 T cell epitopes of Rtx and Ifx. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamze, Moustafa, Meunier, Sylvain, Karle, Anette, Gdoura, Abdelaziz, Goudet, Amélie, Szely, Natacha, Pallardy, Marc, Carbonnel, Franck, Spindeldreher, Sebastian, Mariette, Xavier, Miceli-Richard, Corinne, Maillère, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418239/
https://www.ncbi.nlm.nih.gov/pubmed/28529511
http://dx.doi.org/10.3389/fimmu.2017.00500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418239/
https://www.ncbi.nlm.nih.gov/pubmed/28529511
http://dx.doi.org/10.3389/fimmu.2017.00500

Ejemplares similares